Rules 4.7.3 and 4.10.3 ASX Listing Rules Appendix 4G (current at 17/7/2020) Page 1 Appendix 4G Key to Disclosures Corporate Governance Council Principles and Recommendations Name of entity TrivarX Limited ABN/ARBN Financial year ended: 58 008 130 336 30 JUNE 2026 Our corporate governance...
Appendix 4G
Filed with ASX ·
On 6ix: 6ix.com/news/appendix-4g-279
6ix hasn’t read this filing yet.
Earlier from TrivarX
- Corporate Governance Statement
- 2026 Annual Report
- Stabl-Im Clinical Development Update
- Notice of AGM and Closing Date for Director Nominations
- Appendix 4E - Preliminary Final Report
Later from TrivarX
- Notification of cessation of securities - TRI
- Change of Director's Interest Notice - Chris Ntoumenopoulos
- Change of Director's Interest Notice - David Trimboli
- Syntro Health Appointed to Support Stabl-Im Clinical Program
- Letter to Shareholders & Notice of AGM & Proxy Form
Follow TrivarX into a list and get an email when it puts out news.
Follow TrivarX